Related content

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

By Thervet Eric   Legendre Christopher   Beaune Philippe   Anglicheau Dany  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 37-47

Future Medicine

Access to resources Recommend Favorite

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response

By Tsai Ming-Hsien   Lin Keh-Ming   Hsiao Mei-Chun   Shen Winston W   Lu Mong-Liang   Tang Hwa-Sheng   Fang Chun-Kai   Wu Chi-Shin   Lu Shao-Chun   Liu Shu Chih   Chen Chun-Yu   Liu Yu-Li  

Pharmacogenomics, Vol. 11, Iss. 4, 2010-04 ,pp. : 537-546

Future Medicine

Access to resources Recommend Favorite

Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism

By Porcelli Stefano   Fabbri Chiara   Spina Edoardo   Serretti Alessandro   De Ronchi Diana  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1101-1115

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450 polymorphisms and drug-induced interstitial lung disease

By Schwaiblmair Martin   Behr Werner   Foerg Wolfgang   Berghaus Thomas  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 12, 2011-12 ,pp. : 1547-1560

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450 Polymorphisms as Risk Factors for Steroid Hormone-Related Cancers

By Friedberg T.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 2, 2001-01 ,pp. : 83-91

Adis International

Access to resources Recommend Favorite